Volume 69 Issue 3, 1 March 1994

eph, the largest known family of putative growth factor receptors

• NL Tuzi
• WJ Gullick

Establishment of new ovarian and colon carcinoma cell lines: differentiation is only possible by cytokeratin analysis

• VJ Möbus
• R Moll
• R Kreienberg

Polymerase chain reaction allelotyping of human ovarian cancer

• RJ Osborne
• V Leech

Identification of a cell-surface glycoprotein associated with normal mammary and extramammary epithelial cells

• SA Imam
• MR Stampfer
• CR Taylor

Rapid detection of prognostic genetic factors in neuroblastoma using fluorescence in situ hybridisation on tumour imprints and bone marrow smears

• CPF Taylor
• AG McGuckin
• D Sheer

Inactivation of O⁶-alkylguanine-DNA alkyltransferase in human peripheral blood mononuclear cells by temozolomide

• SM Lee
• N Thatcher
• GP Margison

Initial radiation-induced DNA damage in human tumour cell lines: a correlation with intrinsic cellular radiosensitivity

• JM Ruiz de Almodóvar
• MI Núñez
• GG Steel

Inhibition of leukaemia cell proliferation by folic acid–polylysine-mediated introduction of c-myb antisense oligodeoxynucleotides into HL-60 cells

• G Citro
• C Szczylik
• B Calabretta

Wild-type p53 is required for apoptosis induced by growth factor deprivation in factor-dependent leukaemic cells

• Y-M Zhu
• DA Bradbury
• NH Russell

Effects of photodynamic therapy on xenografts of human mesothelioma and rat mammary carcinoma in nude mice

• SL Gibson
• TH Foster
• R Hilf

Comparative evaluation of cisplatin and carboplatin sensitivity in endometrial adenocarcinoma cell lines

• V Rantanen
• S Grénman
• R Grénman

Comparability of naevus counts between and within examiners, and comparison with computer image analysis

• JF Aitken
• A Green
• NG Martin

Changes in tumour blood flow, oxygenation and interstitial fluid pressure induced by pentoxifylline

• I Lee
• Y Boucher
• RK Jain

Effects of the ACTH(4-9) analogue, ORG 2766, on vincristine cytotoxicity in two human lymphoma cell lines, U937 and U715

• B Kiburg
• AA van de Loosdrecht
• PC Huijgens

Clearance of circulating radio-antibodies using streptavidin or second antibodies in a xenograft model

• D Marshall
• RB Pedley
• RHJ Begent

Environmental and dietary risk factors for nasopharyngeal carcinoma: a case-control study in Zangwu County, Guangxi, China

• YM Zheng
• P Tuppin
• G de Thé

The prognostic value of preoperative serum levels of CA 19-9 and CEA in patients with pancreatic cancer

• J Lundin
• PJ Roberts
• C Haglund

Defining a high mortality risk group among women with primary breast cancer

• T Nordén
• A Lindgren
• L Holmberg

Evaluation of a new tumour marker in patients with non-small-cell lung cancer: Cyfra 21.1

• A van der Gaast
• CHH Schoenmakers
• TAW Splinter

Prognostic significance of histopathological subtypes in stage I pure yolk sac tumour of the ovary

• H Sasaki
• M Furusato
• Y Terashima

A phase I/II trial of recombinant human granulocyte-macrophage colony-stimulating factor in the intensification of cisplatin and cyclophosphamide chemotherapy for advanced ovarian cancer

• S Kehoe
• CJ Poole
• GRP Blackledge

rhGM-CSF ameliorates neutropenia in patients with malignant glioma treated with BCNU

• R Rampling
• W Steward
• D Eckley

Flow cytometric analysis of S-phase fraction in breast carcinomas using gating on cells containing cytokeratin

• S Wingren
• O Stål
• B Nordenskjöld

Immunoradiometric detection of pS2 and total cathepsin D in primary breast cancer biopsies: their correlation with steroid receptors

• S Marsigliante
• L Biscozzo
• C Storelli

Intratumoral oestrone sulphatase activity as a prognostic marker in human breast carcinoma

• TRJ Evans
• MG Rowlands
• RC Coombes

A prospective study of serum tumour markers carcinoembryonic antigen, carbohydrate antigens 50 and 242, tissue polypeptide antigen and tissue polypeptide specific antigen in the diagnosis of pancreatic cancer with special reference to multivariate diagnostic score

• PA Pasanen
• M Eskelinen
• E Alhava

Tumour cell detection in the bone marrow of breast cancer patients at primary therapy: results of a 3-year median follow-up

• N Harbeck
• M Untch
• W Eiermann

Temporary regression of recurrent squamous cell carcinoma of the head and neck is achieved with a low but not with a high dose of recombinant interleukin 2 injected perilymphatically

• G Cortesina
• A De Stefani
• G Forni

A comparative analysis of management and prognosis in stage I and II fallopian tube carcinoma and epithelial ovarian cancer

• AC Rosen
• P Sevelda
• HR Rosen

Soluble E-cadherin fragments increased in circulation of cancer patients

• M Katayama
• S Hirai
• I Kato

p53 protein in low-grade astrocytomas: a study with long-term follow-up

• P Iuzzolino
• C Ghimenton
• M Barbareschi

Diet and subsequent survival in women with breast cancer

• D Ingram

A pilot study to evaluate the effects of C1 esterase inhibitor on the toxicity of high-dose interleukin 2

• AC Ogilvie
• JW Baars
• J Wagstaff

The phase of the menstrual cycle has no influence on the disease-free survival of patients with mammary carcinoma

• Th Wobbes
• CMG Thomas
• LVAM Beex

Mediastinal large-cell lymphoma with sclerosis (MLCLS)

• AZS Rohatiner
• JS Whelan
• TA Lister

Superficial photodynamic therapy with topical 5-aminolaevulinic acid for superficial primary and secondary skin cancer

• F Cairnduff
• MR Stringer
• SB Brown

Immunohistochemical detection of mutant p53 protein in epithelial ovarian cancer using polyclonal antibody CMI: correlation with histopathology and clinical features

• J Renninson
• BW Baker
• D Crowther

Mucin-associated sialosyl-Tn antigen expression in gastric cancer correlates with an adverse outcome

• JL Werther
• S Rivera-MacMurray
• SH Itzkowitz

Stimulation of erythropoiesis by the non-steroidal anti-androgen nilutamide in men with prostate cancer: evidence for an agonistic effect?

• A Decensi
• R Torrisi
• V Fontana

Tamoxifen treatment in premenopausal breast cancer patients may be associated with ovarian overstimulation, cystic formations and fibroid overgrowth

• I Cohen
• DJD Rosen
• D Yigael

Soluble IL-2 α and ovarian cancer

• DPJ Barton

Reply to the letter from Dr Barton

• OJ Owens

Reducing the Risk of Cancers

• M Law

Therapy of Haemopoietic Neoplasia

• CH Poynton

Atlas of Breast Cancer

• JR Benson
• M Baum

Erratum